Multi-Site Clinical Trials for the Pulmonary Trials Cooperative (PTC) (U01)

The summary for the Multi-Site Clinical Trials for the Pulmonary Trials Cooperative (PTC) (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Multi-Site Clinical Trials for the Pulmonary Trials Cooperative (PTC) (U01): This funding opportunity announcement (FOA) requests U01 applications proposing a single, pragmatic clinical trial in adults with chronic pulmonary diseases. Each successful applicant will serve as a Protocol Leadership Group (PLG) for a new type of clinical research network: the Pulmonary Trials Cooperative (PTC). The PTC is a cooperative program that includes multiple PLGs and a Network Management Core (NEMO). The PTC is designed to conduct multiple clinical trials in both inpatient and outpatient settings in adults with a variety of chronic pulmonary diseases, including but not limited to interstitial lung disease (ILD), pulmonary hypertension (PH), chronic obstructive pulmonary disease (COPD), sarcoidosis, and obstructive sleep apnea, but excluding asthma and acute lung injury and critical care. Studies, which may include both Phase 2 and Phase 3 simple, pragmatic clinical trials, will evaluate the efficacy or effectiveness of promising new or existing therapies. This FOA solicits applications for PLGs, which will have primary responsibility for developing a protocol and supporting a Lead Investigator for that protocol in the conduct and analyses of the related trial. A companion FOA (RFA-HL-15-016) requests applications for NEMO.

Federal Grant Title:	Multi-Site Clinical Trials for the Pulmonary Trials Cooperative (PTC) (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HL-15-015
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.233, 93.838
CFDA Descriptions:	National Center on Sleep Disorders Research; Lung Diseases Research
Current Application Deadline:	Oct 20, 2014
Original Application Deadline:	Oct 20, 2014
Posted Date:	Aug 14, 2014
Creation Date:	Aug 14, 2014
Archive Date:	Nov 20, 2014
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public housing authorities/Indian housing authorities
City or township governments
Native American tribal governments (Federally recognized)
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Independent school districts
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
County governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-015.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARR...; • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...; • Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabet...; • Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U0...; • NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Pare...; • Ancillary Studies in Clinical Trials (R01); • Opportunity PA-08-021; • Research Demonstration and Dissemination Grants (R18)
More Grants from the National Institutes of Health: • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...; • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...; • Immune Tolerance Network (UM1 Clinical Trial Required); • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...; • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...